Standard treatment for grade 1/2, non-functional, unresectable GEP-NETs is monotherapy with an SSA or a targeted drug, such as the mTOR inhibitor everolimus. In poor-prognostic subgroups ...

Expert Rev Anticancer Ther. 2012;12(12):1545-1547. Many other clinical trials aimed at optimizing sequential therapy in mRCC are currently ongoing and their results are eagerly awaited in order to ...

TSC-associated epilepsy is treated with a variety of antiepileptics, including mTOR inhibitors like everolimus (Afinitor), which is FDA-approved as an "adjunctive treatment of refractory TSC ...